The British pharmaceutical laboratory AztraZeneca confirmed on December 27 that its experts have found a way to make its Kovi 9 vaccine 100% effective. This is good news as the British government is preparing to launch a nationwide vaccination campaign in early 2021, which has given great hope to the vaccine because it is cheap and easy to store.
ADVERTISING
Pascal Soriot, director general of the AztraZeneca Laboratory, told the Sunday Times that the vaccine, developed in collaboration with the University of Oxford, was “100% effective against the worsening form of Kovid 19”. He explained that experts have found a way to vaccinate twice, one dose per person, to increase the effectiveness of the vaccine.
Please note that according to the results of a semi-experimental study conducted in the UK and Brazil, the AztraZeneca laboratory vaccine is only about 70% effective, which is lower than the effective BioNTech / Pfizer and Moderna vaccines. More than 90% accuracy.
However, experts at the AztraZeneca laboratory explained that during the trial, people were divided into two groups, with the first group receiving two injections at a time. One dose apart a month. But the operation was confusing, with the first time some received only half a dose. For this first group, the efficiency result is 90%. The second group received only one injection but two doses at a time. For this group, the efficiency result is only 62%.
The AztraZeneca laboratory vaccine is the most anticipated because it is cheaper at about $ 4 per dose and can be stored in Refrigerate normally without refrigeration at temperatures below 80 ° C, unlike Pfizer vaccines.
However, the British Medicines Authority is preparing to give AztraZeneca vaccine the green light soon to launch the campaign on January 4. Britain orders 100 million doses of AztraZeneca vaccine. Regarding the 19 new Kovid virus, the director of the AztraZeneca laboratory claimed that it did not affect the effectiveness of the vaccine. However, the laboratory will begin preparations for a new vaccine.